Nobuhisa Iwata
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Stepwise Upregulation of Microglial Genes through the Slow Progression of Amyloid Pathology in Alzheimer's Disease Model Mice.
Journal: Biological & pharmaceutical bulletin
Published: September 02, 2026
Trem2 R47H mutation shows mild, but functionally divergent alterations in microglial phenotypes compared to Trem2 deficiency in aged AppNL-F knock-in mice.
Journal: Experimental neurology
Published: April 20, 2026
Somatostatin receptor subtypes 1 and 4 regulate neprilysin, the major amyloid-β degrading enzyme in brain.
Journal: Journal of Alzheimer's disease : JAD
Published: November 19, 2025
Cell type- and neuronal differentiation-dependent MME 5'UTR splice variants with distinct translational outputs in human cells.
Journal: Journal of biochemistry
Published: November 10, 2025
The tale of donanemab: God is in the details.
Journal: Journal of Alzheimer's disease : JAD
Published: September 03, 2025
Proline-Rich Transmembrane Protein 2 Is Variably Expressed Across Excitatory and Inhibitory Neurons in Mouse Motor Circuits.
Journal: The Journal of comparative neurology
Published: March 08, 2025
The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease.
The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: November 11, 2024
The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain.
Journal: Science signaling
Published: August 06, 2024
Proline-rich transmembrane protein 2 regulates the magnitude and frequency of dopamine release by repetitive neuronal stimuli in the striatum of L-dopa-treated mice.
Journal: Neuropsychopharmacology reports
Published: June 29, 2024
Identification and Characterization of Synaptic Vesicle Membrane Protein VAT-1 Homolog as a New Catechin-Binding Protein.
Journal: Biological & pharmaceutical bulletin
Published: February 25, 2024
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemab.
Journal: Life science alliance
Published: February 08, 2024
Proline-rich transmembrane protein 2 knock-in mice present dopamine-dependent motor deficits.
Journal: Journal of biochemistry
Published: August 05, 2023
Last Updated: 09/26/2026